Welcome to our dedicated page for KNEAT COM news (Ticker: KSIOF), a resource for investors and traders seeking the latest updates and insights on KNEAT COM stock.
kneat.com, inc. develops digital validation and quality process automation software for highly regulated industries. Its Kneat Gx platform is used to manage validation disciplines end to end, with compliance features tied to GxP environments, data integrity, 21 CFR Part 11/Annex 11 requirements, and ISO 9001 and ISO 27001 certification.
Company news commonly covers customer agreements with life sciences, CDMO, pharmaceutical packaging, and biopharma manufacturing organizations; financial results and shareholder communications; platform capabilities including optional AI tools; and the company’s State of Validation research on digitization, validation workload, and compliance practices.
A global medical devices manufacturer has signed a three-year Master Services Agreement with Kneat to digitize its validation processes. The client, headquartered in Germany, employs over 11,000 people and operates 30+ production sites across 15 countries in Europe, Asia and the Americas. The company provides solutions to pharma, biotech and cosmetic industries, including pharmaceutical packaging, drug delivery systems, diagnostic devices, and digital healthcare solutions. They plan to implement the Kneat Gx platform for Commissioning, Qualification and Validation (CQV) processes.